Pre-referral injectable artesunate and outcomes of childhood severe malaria at a secondary health facility in North-central Nigeria: a cross-sectional study
Open Access
- 18 April 2025
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 24 (1) , 1-9
Abstract
The use of pre-referral injectable artesunate is among the strategies adopted to improve the outcome of childhood severe malaria in Nigeria. However, the extent of its implementation and impact on outcomes remain unknown. This study assessed the pre-referral treatment with injectable artesunate for severe malaria, associated factors, and hospitalisation outcomes (discharge or death) among a cohort of children managed at a secondary health facility in Nigeria. This cross-sectional study included children diagnosed with severe malaria admitted to a secondary health facility in Nigeria. Data on pre-referral treatment with injectable artesunate and other medications, demographics, clinical features, and outcomes among children were prospectively gathered and analysed them using SPSS. Of the 137 children recruited, 7(6.3%) received pre-referral injectable artesunate; other medications received included antipyretics (53;47.3%), antibiotics (16;14.3%), artemisinin-based combination therapy (14;12.5%), and supplements (11;9.8%). Pre-referral injectable artesunate treatment was not associated with age, sex, and socioeconomic status (p > 0.05), and most of the clinical features except impaired consciousness with an adjusted odds ratio of 17.876 (95% CI 2.050 to 155.883). Of the 137 children, two deaths occurred, with a crude mortality rate of 1.5% (95% CI 0.04–5.2%). Pre-referral injectable artesunate treatment was not associated with hospitalisation durations and outcomes (death or discharge). This study showed a very low uptake of pre-referral injectable artesunate among children with severe malaria, and the presence of impaired consciousness increased the odds of a child receiving injectable artesunate. In addition, most children with severe malaria had received pre-hospitalisation medications that were mostly inappropriate.Keywords
This publication has 13 references indexed in Scilit:
- Severe malaria intervention status in Nigeria: workshop meeting reportMalaria Journal, 2024
- Determinants of outcomes of childhood severe Malaria: A multi-centric studyMedical Journal Armed Forces India, 2023
- Drivers of inappropriate antibiotic use in low- and middle-income countriesJAC-Antimicrobial Resistance, 2023
- Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational studyPLOS Medicine, 2023
- Rectal artesunate as pre-referral treatment for severe malaria in sub-Saharan Africa: still a long way to goThe Lancet Global Health, 2022
- Severe malariaMalaria Journal, 2022
- Exploring knowledge on danger signs of common childhood illnesses and associated factors among mothers of under-five children in Central Tigrai, Ethiopia: a cross-sectional studyGERMS, 2020
- Use of pre-hospital medication in children presenting with malaria to the emergency unit of Mulago Hospital, Uganda: A descriptive study2017
- Determinants of delay in malaria care-seeking behaviour for children 15 years and under in Bata district, Equatorial GuineaMalaria Journal, 2016
- Improving childhood malaria treatment and referral practices by training patent medicine vendors in rural south-east NigeriaMalaria Journal, 2009